Unlocking revenue through Gross-to-Net excellence in Pharma

In our upcoming webinar, we delve into the role of Gross-to-Net (GtN) investments in driving profitability and revenue growth for global pharmaceutical companies. 

While optimizing launch pricing is often the focus for pharmaceutical market access professionals, our experience globally indicates that GtN optimization is frequently overlooked leading to missed opportunities and revenue left on the table. 

During this webinar, we dive into the role of GtN excellence in driving profitability and revenue growth for global pharmaceutical companies. Participants can be expected to learn: 

• Common GtN pitfalls: Identify typical GtN pitfalls and areas leading to revenue leakage. 
• Methodological approaches: Learn analytical approaches to identify and optimize GtN opportunities, allowing you to capitalize on untapped revenue streams. 
• Best-in-class GtN concepts: Understand the logic and…